ACP-204

DRUG4 trials

Sponsors

ACADIA Pharmaceuticals Inc.

Conditions

Alzheimer's Disease PsychosisLewy Body Dementia Psychosis

Phase 2

ACP-204 in Adults With Alzheimer's Disease Psychosis

RecruitingNCT06159673

ACADIA Pharmaceuticals Inc.Alzheimer's Disease Psychosis

Start: 2023-11-14End: 2028-02-01Target: 1074Updated: 2026-08-31

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

RecruitingNCT07029581

ACADIA Pharmaceuticals Inc.Lewy Body Dementia Psychosis

Start: 2025-08-06End: 2028-03-01Target: 180Updated: 2026-08-24

Phase 3

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Enrolling by invitationNCT06194799

ACADIA Pharmaceuticals Inc.Alzheimer's Disease Psychosis

Start: 2024-04-23End: 2029-05-01Target: 752Updated: 2026-08-05

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

Enrolling by invitationNCT07095465

ACADIA Pharmaceuticals Inc.Lewy Body Dementia Psychosis

Start: 2025-11-14End: 2029-03-01Target: 126Updated: 2026-07-24

Related Papers

Plasma Biomarker Characterization of Alzheimer’s Disease Psychosis in Study ACP‐204‐006

Alzheimer s & Dementia2025-12-01